Homepage > Rare diseases > Search

Search for a rare disease

*
(*) mandatory field

Blomstrand lethal chondrodysplasia

Suggest an update
Your message has been sent Your message has not been sent. Please contact an administrator.
Disease definition

Blomstrand lethal chondrodysplasia (BLC) is a neonatal osteosclerotic dysplasia characterized by advanced endochondral bone maturation, very short limbs, dwarfism and prenatal lethality.

ORPHA:50945

Classification level: Disorder

Synonym(s):
  • BLC
  • BOCD
  • Blomstrand chondrodysplasia
  • Blomstrand osteochondrodysplasia
  • Chondrodysplasia, Blomstrand type

Prevalence: <1 / 1 000 000

Inheritance: Autosomal recessive

Age of onset: Antenatal, Neonatal

ICD-10: Q78.8

ICD-11: LD24.1Y

OMIM: 215045

UMLS: C1859148

MeSH: C537914

GARD: 914

Summary
Epidemiology

To date, less than 10 cases have been described in the literature.

Clinical description

BLC is a congenital disorder characterized by a low birth weight, facial dysmorphism (widely spaced and protruding eyes (which typically show cataract), depressed nasal bridge, short columella, long philtrum, macroglossia, protruding tongue, severe micrognathia), short trunk, narrow thorax and severe rhizo-meso-acromelic shortness of the limbs. Other anomalies also observed include tooth and mammary gland development defects, hypoplastic lungs, aorta coarctation, and bowel malrotation. Two forms of BCL, have been described: type I which is the severe, classical form and type II which has less severe features (such as absence of short trunk or, severely shortened arms but moderately shortened legs).

Etiology

BLC is caused by inactivating homozygous or compound heterozygous mutations in PTH1R (3p22-p21.1) which encodes the parathyroid hormone (PTH)/parathyroid-hormone-related peptide (PTHrP) receptor (PTH1R). These mutations result in the decrease in binding or response to PTH and PTHrP.

Diagnostic methods

Diagnosis is based on the clinical and radiological characteristics which show generalized increase in bone density with advanced ossification, severe shortness of the long bones with wide metaphyses and club-shaped distal ends, long narrow thorax, calcified hyoid bone and laryngeal cartilage and underdeveloped viscerocranium. Histopathological examination shows an important acceleration of the endochondral ossification in tubular bones, narrow cartilages of the epiphyses and large epiphyseal ossification centers. Diagnosis is confirmed by the genetic screening of PTH1R.

Differential diagnosis

Differential diagnosis includes primary failure of tooth eruption (see this term) and other lethal short limbed dwarfisms.

Antenatal diagnosis

Prenatal diagnosis is achieved by sonographic examination showing polyhydramnios, hydrops fetalis and a fetus with very short limbs, nuchal edema, macroglossia, a protuberant abdomen, internal anomalies and markedly advanced endochondral bone formation.

Genetic counseling

Transmission is autosomal recessive. Genetic counseling should be offered to at-risk couples (both individuals are carriers of a disease-causing mutation) informing them of the 25% risk of having an affected child.

Prognosis

Both forms of BLC are lethal either prenatally or shortly after birth.

Last update: November 2014 - Expert reviewer(s): Pr Harald JÜPPNER - Dr Caroline SILVE
A summary on this disease is available in Français (2005) Español (2014) Deutsch (2005) Nederlands (2014)
The documents contained in this website are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.